WOW! POT CURES LIVER CANCER I KNEW IT!!!! Can-Fite cannabis compound inhibits liver cancer growth Apr. 05, 2021 7:43 AM ETCan-Fite BioPharma Ltd. (CANF) Can-Fite BioPharma(NYSEMKT:CANF)hascompletedpre-clinical studies demonstrating that a CBD rich T3/C15 cannabis fraction induces inhibition of liver cancercell growth. T3/C15 cannabis fraction inhibited the growth of liver HEP-3b hepatocellular carcinoma cells via the A3 adenosine receptor (A3AR) by inhibiting Wnt- and NF-kappa B-related regulatory pathways, known to be highly active in controlling the growth of liver cancer cells. An A3AR antagonist, MRS1523 reversed this effect demonstrating that the inhibitory effect is mediated via Can-Fite’s target, A3AR. Can-Fite drug candidate Namodenoson is expected to enter a Phase III study in Q4 2021. The Company has filed patent applications protecting its discovery of cannabinoid-based therapies where the A3AR target is overexpressed including liver cancer. According to Adroit Market Research, the medical cannabis market is projected to grow at a CAGR of 29% to $56.7B by 2026. DelveInsight estimates the HCC drug market will reach $3.8 B in 2027 in the G8 countries. CANF shares up 5.7% premarket trading at $2.59.<---- CANF is A Gummy Of The Day!
--Agrify announces receipt of $3.5M purchase contract with WhiteCloud 07:13 AGFY --Bluegreen Vacations Holding to acquire outstanding Bluegreen Vacations shares 07:06 BVH, BXG Bluegreen Vacations… --Morgan Stanley upgrades MGM Resorts to Overweight after Vegas visit 07:05 MGM
Coupang initiated with a Hold at Deutsche Bank 06:53 CPNG William Blair upgrades Gogo, sees shares going back to $13-$16 06:45 GOGO Azure Power sells solar rooftop portfolio to Radiance Renewables for $73.5M » 06:34 AZRE Azure Power lowers FY22 revenue view to $236M-$249M from $245M-$249M 06:37 AZRE Consensus $283.67M. In addition, the company now expects G&A to be approximately $20M compared to previous guidance which assumed approximately $22M inclusive of the rooftop portfolio. The company also expects the run rate CFe to improve as a result of this transaction. The company further expects to take an estimated $40M-$60M one-time charge subject to purchase price adjustments and other conditions related to the sale of its non-core solar rooftop portfolio. Here is this co with the crappy hair dryers and such it just keeps going up. Can't fight this anymore... Mohawk Group initiated with a Buy at BTIG 05:56 MWK BTIG analyst Marvin Fong initiated coverage of Mohawk Group with a Buy rating and $45 price target. The analyst says that while investors may view Mohawk as a play on the near- to medium-term online marketplace aggregation opportunity, he's more constructive on the company's core e-commerce platform. Fong believes the latter "will endure long after the land-grab for marketplace sellers has peaked." Having both organic and acquisition "growth engines" make Mohawk Group shares a "compelling investment," Fong tells investors in a research note. The analyst sees 41% potential upside in the stock. MWK
It started with a single man at home in his underwear watching stagnant CCV videos of boardwalks and traffic streets in Vegas. The South strip. Day and night. Night and Day there;s that homeless guy again! Is that a drug deal. Don't get in that UBer I don't trust that guy.. I watch... Then I start to see people in the empty streets walking first slowly then more they came out of the darkness... people they looked happy more of them MORE!! It's PEOPLE IT's PEOPLE!!!! Caesars and MGM higher after Morgan Stanley takes in Vegas recovery!!!!! Apr. 05, 2021 8:07 AM ETMGM Resorts International (MGM) Morgan Stanley upgrades Caesars Entertainment(NASDAQ:CZR)and MGM Resorts(NYSE:MGM)to Overweight ratings from Neutral after a trip to LasVegas indicates a fast, strong recovery is in play. Analyst Thomas Allen: "While we thought it was because of Spring Break & March Madness, numerous market participants told us their bookings were stronger than current occupancy, booking windows were extending and continued to build. Our experience was the South Strip (CZR/MGM properties) was busier than the North Strip (WYNN/LVS properties) as the market still lacked convention visitors and had made up for it with more price sensitive, typically lower quality leisure customers. However, those customers illustrated demand for Vegas is there and are spending more per visitor than they have in the past." < they got dem' Stimmi checks!!!!
Van You're Up.... Drive Shack Inc.(NYSE:DS) is a leader in the golf industry with a business of operating 60 golf course properties across the U.S.
This is just a hunch but I feel the time is NOW for Agrify>> This is a combo of farming & tech... You didn't think those worlds connected.... Agrify $25 Million U.S. IPO-------------- Jan. 25, 2021 2:28 PM ETAgrify Corporation (AGFY) The firm provides proprietary hardware and software to controlled environment agriculture firms in North America. AGFY has grown revenue sharply from a small base, is operating in a promising industry and the IPO appears reasonably valued>>> AGFY is growing topline revenue quickly in a promising growth industry Company & Technology Burlington, Massachusetts-based Agrify was founded to provide proprietary hardware and software to enhance efficiency of indoor agriculture operations. Management is headed by CEO Raymond Chang, who has been with the firm since 2019 and was previously founder of GigaMedia (GIGM). GigMedia was a good co in the old days! April 1 Company beats no one noticed-- losing money but revenue ramp- Agrify beats on revenue Apr. 01, 2021 7:13 AM ETAgrify Corporation (AGFY) Agrify(NASDAQ:AGFY): Q4 Net loss of $13.06M Revenue of $4.35M (+160.5% Y/Y)beats by $0.61M. Shares+3.37%PM. Now follow my reasoning.... Agrify reports Q4 revenue $4.35M, two est. $3.74M » Today's news--- (as published above)-- Agrify announces receipt of $3.5M purchase contract with WhiteCloud So 1 contract almost equals a Qtr's worth of revenue.... Ladies & gentleman MORE than a gummy! I WILL BE ADDING AGRIFY TO THE Phantasma AT THE OPEN!!!! ~stoney And now the icing on the cake--- BACKDOOR POT PLAY!!!! Agrify enters binding LOI for build-out of R&D facility in Atlantis partnership 03/16 AGFY Agrify Corporation announced it has entered into a binding letter of intent, which sets forth the principal terms of a partnership currently being negotiated with Atlantis Hydroponics to build out a 2,500 square foot research and development facility. The new R&D facility will be at the Atlantis location in Georgia, where Atlantis has a license to grow hemp in the state. The R&D facility is expected to focus on increasing concentrations of certain phytochemicals and metabolites via the manipulation and control over abiotic elements in the growing environment, such as temperature and light spectrum. Agrify and Atlantis believe this research will lead to further stabilization and control over the chemotypic expression, and ultimately to safer and more consistent phyto-derived medicines and products. Testing capabilities at the R&D facility will also include mechanical component testing and improvements, new product development evaluation, remote customer "simulation" studies, and LED light mapping and evaluation. The completed R&D facility will be comprised of Agrify's Vertical Farming Units, Integrated Grow Racks, and Agrify Insights software platform, and operations are expected to commence in April of 2021, subject to entry into a definitive agreement. AGFY-$ 12.62<----------